EnWave Successfully Enriches nutraDRIED(TM) Fruit Products with B-galactosidase
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/19/13 -- EnWave
Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the
"Company") announced today that it has successfully used its
proprietary Radiant Energy Vacuum ("REV(TM)") dehydration technology
to enrich nutraDRIED(TM) fruit products with the enzyme
B-galactosidase; an enzyme responsible for breaking down lactose, a
sugar found mainly in milk and other dairy products. The enzyme
retained 90% of its activity after several months of storage at room
temperature within the fruit's natural structure at 10% moisture.
This result validates the potential use of nutraDRIED(TM) food
products as delivery vehicles for nutraceuticals and bioactive
The nutraDRIED(TM) fruit enriched with B-galactosidase is designed to
be used as an ingredient in cereal mixes, targeting lactose
intolerant individuals. The enzyme gradually releases from the fruit,
breaking down the lactose before the milk enters the large intestine,
thus avoiding the negative side effects caused by lactose
intolerance. Approximately 20% of Canadians and around 30 million
American adults have some degree of lactose intolerance diagnosed by
the age of 20. To the Company's knowledge, this is the first time
dried fruit has been used as a carrier for B-galactosidase.
"The ability to enrich food products with enzymes via our proprietary
process could open up many new unique commercial opportunities,"
stated Dr. Tim Durance, Chairman & Co-CEO. "More specifically,
enriching nutraDRIED(TM) fruit with B-galactosidase could provide
lactose intolerant people with the ability to consume cereal and milk
without having to take separate tablets to break down the lactose."
EnWave Corporation is a Vancouver-based industrial technology company
developing commercial applications for its proprietary Radiant Energy
Vacuum (REV(TM)) dehydration technology. The company licensed REV(TM)
technology to Milne Fruit Products Inc in 2011, its first major U.S.
customer, to support a launch of healthy berry snacks and powders
across most major markets in North America. More recently, EnWave
licensed REV(TM) technology to one of its Tier 1 multinational
collaborators from the list below. In addition, EnWave has entered
into a wide range of research and collaboration agreements with an
expanding list of multinational companies, including Nestle,
Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries,
Hormel, Bonduelle, Cherry Central, Sun-Maid Growers, Gay Lea and
Merck. EnWave is introducing REV(TM) as a new dehydration standard in
the food and biological material sectors: potentially faster and
cheaper than freeze drying, with better end product quality than air
drying or spray drying.
EnWave currently has six REV(TM) platforms: commercial-scale
nutraREV(R) and MIVAP(R) are used in the food industry to dry fruits,
vegetables, meat, herbs and seafood quickly and at low-cost, while
maintaining high levels of nutrition, taste, texture and colour. The
Company is also developing powderREV(TM) for bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of
pastes, gels, liquids, or particulates; and bioREV(TM) and
freezeREV(TM) as new methods to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More information
about EnWave is available at www.enwave.net.
Dr. Tim Durance, Chairman & Co-CEO
Safe Harbour for Forward-Looking Information Statements: This press
release may contain forward-looking information based on management's
expectations, estimates and projections. All statements that address
expectations or projections about the future, including statements
about the Company's strategy for growth, product development, market
position, expected expenditures, and the expected synergies following
the closing are forward-looking statements. All third party
references to market information in this release are not guaranteed
to be accurate as the Company did not conduct the original primary
research. These statements are not a guarantee of future performance
and involve a number of risks, uncertainties and assumptions.
Although the Company has attempted to identify important factors that
could cause actual results to differ materially, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Mr. John McNicol
President & Co-CEO
Mr. Brent Charleton
Director of Marketing & Corporate Affairs
Press spacebar to pause and continue. Press esc to stop.